• 1. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 2. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Research of Ethyl 3-hydroxypyridine-4-carboxylate (CAS: 18342-97-7)

Ethyl 3-hydroxypyridine-4-carboxylate (CAS: 18342-97-7) is a significant chemical compound in the field of chemical biology and pharmaceutical research. This compound, characterized by its pyridine core and carboxylate ester functional group, has garnered attention due to its potential applications in drug development and medicinal chemistry. Recent studies have explored its role as a building block for synthesizing novel bioactive molecules, particularly in the context of neurodegenerative diseases and anti-inflammatory agents.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the compound's utility in the synthesis of multifunctional ligands targeting the central nervous system (CNS). Researchers demonstrated that ethyl 3-hydroxypyridine-4-carboxylate serves as a versatile intermediate for the development of compounds with dual activity as cholinesterase inhibitors and NMDA receptor antagonists. This dual mechanism is particularly promising for the treatment of Alzheimer's disease, where current therapies often fall short due to the complexity of the disease pathology.

In addition to its CNS applications, ethyl 3-hydroxypyridine-4-carboxylate has shown potential in oncology research. A recent preclinical study investigated its derivatives as inhibitors of specific kinases involved in cancer cell proliferation. The study, published in Bioorganic & Medicinal Chemistry Letters, reported that certain modifications to the ethyl ester group significantly enhanced the compound's binding affinity to target kinases while maintaining favorable pharmacokinetic properties. These findings suggest that 18342-97-7 could be a valuable scaffold for developing next-generation kinase inhibitors.

The compound's synthetic accessibility has also been a focus of recent research. A 2024 paper in Organic Process Research & Development described an optimized, scalable synthesis route for ethyl 3-hydroxypyridine-4-carboxylate that improves yield and reduces environmental impact compared to traditional methods. This advancement is particularly important for potential industrial-scale production, should any of its derivative compounds progress to clinical trials.

From a mechanistic perspective, computational chemistry studies have provided insights into the molecular interactions of ethyl 3-hydroxypyridine-4-carboxylate derivatives with their biological targets. Molecular docking simulations and quantum mechanical calculations have helped explain the structure-activity relationships observed in experimental studies, guiding the rational design of more potent analogs.

Looking forward, ethyl 3-hydroxypyridine-4-carboxylate continues to be an important compound in medicinal chemistry research. Its structural features offer multiple points for chemical modification, making it a versatile starting material for drug discovery programs. Current research efforts are exploring its potential in additional therapeutic areas, including antimicrobial applications and metabolic disorders. As the understanding of its pharmacological properties deepens, 18342-97-7 is likely to remain a compound of significant interest in the pharmaceutical industry.

• 79451-33-5(4-Pyridinecarboxylicacid, 3-(acetyloxy)-)
• 104612-24-0(7-Isoquinolinecarboxylic acid, 6-hydroxy-, methyl ester)
• 1138444-13-9(tert-Butyl 3-hydroxy-5-methoxyisonicotinate)
• 73776-20-2(Methyl 8-hydroxyquinoline-7-carboxylate)
• 73776-18-8(methyl 3-hydroxyquinoline-4-carboxylate)
• 10128-72-0(methyl 3-hydroxypyridine-4-carboxylate)
• 10128-71-9(3-hydroxypyridine-4-carboxylic acid)
• 16866-66-3(Benzoic acid,2-hydroxy-, 3-pyridinylmethyl ester)
• 18343-02-7(Ethyl 3-(2-ethoxy-2-oxoethoxy)isonicotinate)
• 59786-32-2(Methyl 3-methoxyisonicotinate)